Shareholders of STRATEC SE (Frankfurt: SBS; Prime Standard) approved all agenda items at the company's Annual General Meeting held today, including a dividend of EUR 0.60 per share for the 2024 financial year, matching the previous year's dividend. The total distribution amounts to EUR 7.3 million and will be paid to shareholders via their depositing banks on June 26, 2026, according to a press release.
The meeting, which saw 70.1 percent of the company's registered share capital represented, also ratified the actions of the Board of Management and the Supervisory Board. Shareholders elected PricewaterhouseCoopers GmbH Wirtschaftsprüfungs-gesellschaft (PwC), Frankfurt am Main, as auditor for the 2026 financial year and approved the remuneration report.
STRATEC SE designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and life sciences, along with complex consumables for diagnostic and medical applications. The company covers the entire value chain from development to production and quality assurance. Its partners market the systems, software, and consumables—often with their own reagents—as complete solutions to laboratories, blood banks, and research institutes worldwide.
Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange. Further details about the Annual General Meeting, including voting results, are available at www.stratec.com/agm.
The consistent dividend payout reflects STRATEC's commitment to sharing its financial performance with shareholders, even as the company continues to invest in its core business of developing patented technologies for diagnostic and life science applications. The approval of all resolutions signals strong shareholder confidence in the company's strategic direction and governance.
